ARCH Cites Stability Of Long-Term Investors In Raising $3bn Fund
Fund XII Brings In New And Existing Investors
ARCH Venture Partners brought in $2.975bn for its latest fund to give additional long-term investors a place at the table as the VC firm creates, builds and supports new early-stage biotechnology start-ups.